Pierre-Alain Ruffieux today joins Lonza Group in the role of Chief Executive Officer. Albert Baehny has taken the role of CEO ad interim since November 2019. He will now work with Pierre-Alain to ensure a smooth handover of leadership before returning to his role as Chairman of the Board of Directors.
Pierre-Alain brings with him more than 20 years of experience in biopharmaceuticals, most recently as Head of Global Pharma Technical Operations at Roche, where he oversaw pharmaceutical commercial manufacturing and supply chain operations.
Pierre-Alain joins Lonza at a significant moment of opportunity, supported by increasing global awareness of the critical industry contribution made by pharma and biotech manufacturing technologies. Lonza is well positioned to capitalize on future opportunities, as it refocuses its attention on long-term business growth, supported by a sustained series of confident CAPEX investments.
